Abolishing respiratory complex I decreases in vivo growth of high grade serous ovarian cancer cells and sensitizes to anti-angiogenic therapy
Ivana Kurelac, Beatrice Cavina, Francesca Nanetti, Simona Corra, Manuela Sollazzo, Camelia Alexandra Coadǎ, Marco Grillini, Laura Scalambra, Eleonora Lama, Eleonora Angi, Sonia Anna Minuzzo, Luisa Iommarini, Stefano Indraccolo, A. Porcelli, Giuseppe Gasparre
This study shows that inhibiting respiratory complex I reduces tumor growth and enhances sensitivity to anti-angiogenic therapy in high-grade serous ovarian cancer.
bioRxiv · Mar 3, 2026 · PreprintCancer Biology